Clinical Trial Update: Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Hepsera (adefovir dipivoxil) alone versus Hepsera plus lamivudine in patients with chronic hepatitis B and normal ALT has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepsera (adefovir dipivoxil)
• Lamivudine (lamivudine)

Snippet

Sponsor: University of Washington | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED